Risk for molecular contamination of tissue samples evaluated for targeted anti-cancer therapy.
about
Lung cancer mutation testing: a clinical retesting study of agreement between a real-time PCR and a mass spectrometry test.Mutant KRAS Circulating Tumor DNA Is an Accurate Tool for Pancreatic Cancer Monitoring.Characterization of Factors Affecting the Detection Limit of EGFR p.T790M in Circulating Tumor DNA
P2860
Risk for molecular contamination of tissue samples evaluated for targeted anti-cancer therapy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Risk for molecular contaminati ...... targeted anti-cancer therapy.
@ast
Risk for molecular contaminati ...... targeted anti-cancer therapy.
@en
type
label
Risk for molecular contaminati ...... targeted anti-cancer therapy.
@ast
Risk for molecular contaminati ...... targeted anti-cancer therapy.
@en
prefLabel
Risk for molecular contaminati ...... targeted anti-cancer therapy.
@ast
Risk for molecular contaminati ...... targeted anti-cancer therapy.
@en
P2093
P2860
P1433
P1476
Risk for molecular contaminati ...... targeted anti-cancer therapy.
@en
P2093
Edmond Sabo
Einav Simon
Ibrahim Fahoum
Michael Y Stav
Ofer Ben-Izhak
P2860
P304
P356
10.1371/JOURNAL.PONE.0173760
P407
P577
2017-03-13T00:00:00Z